12th – 13th November GRANADA

Slides:



Advertisements
Similar presentations
Progress Against Ovarian Cancer. 1970–1979 Progress Against Ovarian Cancer 1970– : First effective combination chemotherapy regimen for ovarian.
Advertisements

¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Data Visualization in Molecular Biology Alexander Lex July 29, 2013.
Andrew Emili Ontario Research Chair in Biomarkers of Clinical Management Donnelly Center, UofT Biomarker Discovery 2012 Symposium of Ontario Research Chairs.
Clinical Bioinformatics: the need for CBAS and SCBC in Applied Sciences? Dr James Mah MBBS(Lon), BSc(Hons,Lon). Chair, CBAS 2009 Singapore
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Bioinformatics Training for Dental Researchers Lynn Johnson, Ph.D. University of Michigan.
The NIH Roadmap for Medical Research
Chapter 17 Nursing Diagnosis
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
Integrated Biomedical Information for Better Health Workprogramme Call 4 IST Conference- Networking Session.
Project Funding & New Projects Cancer Care Engineering.
Sage / DREAM Breast Cancer Prognosis Challenge The goal of the breast cancer prognosis challenge is to assess the accuracy of computational models designed.
Using Predictive Classifiers in the Design of Phase III Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute.
Medical Innovation Center Team University of Michigan Executive Director Dr. James Geiger Pediatric Surgery Associate Director Professor Albert Shih Mechanical.
Rachel Liao, PhD Coordinator of the Clinical Working Group and the BRCA Challenge demonstration project for the Global Alliance for Genomics and Health.
Dr Godfrey Grech University of Malta
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Joe Pekny, Professor Chemical Engineering Director, e-Enterprise Center Discovery Park Marietta Harrison, Professor Medicinal Chemistry & Molecular Pharmacology.
Leading the Biomedical Revolution in Precision Health: How Stanford Medicine is Developing the Next Generation of Health Care Annual Stanford Medicine.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
The Basis of Genetics. The Cell Cycle Cell Signaling.
LEARNING SESSIONS. Overview The Learning sessions will focus on: Movement Strengthening, Resource Mobilisation, Youth Employment, Youth Health, Civic.
Module 5: Future 1 Canadian Bioinformatics Workshops
Biomarker introduction Annemieke Aartsma-Rus November
Feedback from Interoperability Workshop: Graham Worsley and David Calder TSA Conference 15 November 2011.
Process Improvement at the Phillips Neighborhood Clinic Dan Hottinger: Process Improvement Chair Rob Fraser: Co-chair.
Bringing Genomics Home Your DNA: A Blueprint for Better Health Genome British Columbia November 18, 2015 / West Vancouver, BC.
Aligning Policy Agendas The case of personalised care and cure for healthy and active ageing Setting the scene for the DG Regio and Flanders Smart Specialisation.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Professor Orla Hardiman HRB Clinician Scientist Innovation Its role in Delivering Better Health Outcomes.
This study is funded by a contract from the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Cancer.
Description of a Process for Enhancing Pre-service Programs to Better Prepare General Education Teachers to Teach Students with Disabilities 2016 CEEDAR.
Grand Challenge Slide Toolkit THIS POWERPOINT INCLUDES A SELECTION OF SLIDES FOR YOU TO CHOOSE FROM WHEN TALKING ABOUT GRAND CHALLENGE – Summary slide.
Evolution-informed Modeling discover biomarkers for precision oncology Li Liu, M.D. August 22, 2016.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
Precision Medicine Market share of over 30% dominated by Oncology applications
Bringing Genomics Home Your DNA: A Blueprint for Better Health
Precision Medicine, Community Engagement, and Native Health
NCT: Gaining Medical Insights and Enhancing Care for Cancer Patients with SAP HANA® Organization National Center for Tumor Diseases (NCT) Heidelberg, part.
D I S C O V E R Y Challenge.
MRC’s Translational Research Funding
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
2017 4R Symposium highlights
EU funding opportunities
Better Science, Better Health: New Healthcare Models
Machine Learning tackles Ocean Health, Heart Health, Lung Cancer, and…
Data Quality: Practice, Technologies and Implications
Cancer Prevention Clinical Trials at [Name of Clinical Site]
Biomedical Sciences Pathway
From Bench to Clinical Applications: Money Talks
Risk of Treatment Failure: Patient Support approaches and strategies
Aurora Briefing for participants 2018 to 2019
Early Cognitive Decline and the Aging Brain - Overview
Professional Development Workshop on [title]
Jesper B. Andersen, Snorri S. Thorgeirsson  Gastroenterology 
The International Consortium for Personalised Medicine
How will cancer be treated in the 21st century?
Registration is Open:
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Group 3 Group 3 The “Omes” Precision Cancer Medicine
Results from our participation in
SRIA Roadmap Jonathan Pearce
Objectives of the Training Workshop
Next Generation Sequencing Market. Report Description and Highlights According to Renub Research market research report “Next Generation Sequencing (NGS)
How Is Precision Medicine Transforming The Health Care Industry?
Presentation transcript:

12th – 13th November GRANADA http://oncothon.ptsgranada.com/ ONCOTHON

What is Oncothon? Meeting organized by PTS in the framework of the ONCONET SUDOE European project 20 Institutions from the SUDOE space to analyze and compare professional practices and public health policies regarding cancer prevention and diagnosis, therapeutic innovation and medical data processing Meeting with a hackathon format in which professionals from different areas (mainly Bioinformatics and Biomedical Research) work together during two days to know and explore the potential of cancer genomics data and the possibilities of the “cancer interception” concept

Topics http://oncothon.ptsgranada.com/

Challenges CANCER INTERCEPTION To propose a strategy for developing diagnostic test and associated surrogate endpoints that would serve to: Identify those individuals with premalignancies who are most likely to progress. Accurately measure the clinical response of those individuals with high cancer risk, who will receive treatment

Challenges BIG DATA & CANCER GENOMICS To propose ideas and solutions about challenging questions in the context of cancer genomics data analysis Integrating Different Omics for Biomarker Discovery Defining Gene Signature for Disease Progression or Survival Drug Discovery and Personalized Treatments Characterization of Cancer Driver Genes and Mutation Discovering Tumor Subtypes from Genomics Data (Integrative Clustering)

How was it organized? Keynote talks Speakers to propose questions, limitations of current methods, etc. in “workshop” sessions in both topics Team Work Propose solutions, ideas, proof of concept or prototypes Five minutes presentation Two 3,000 € awards in each topic

ONCOTHON Keynote talks 10 minutes talks Software demos, ideas that participants can use Worked with the the teams, guiding and mentoring

ONCOTHON

ONCOTHON 91 participants 6 Teams in Big Data & Cancer Genomics 4 Teams in Cancer Interception

ONCOTHON

ONCOTHON